A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR by Wun, Kwok S. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
ARTICLE
JEM © The Rockefeller University Press  $30.00
Vol. 205, No. 4,  April 14, 2008  939-949 www.jem.org/cgi/doi/
939
10.1084/jem.20072141
                   TCRs interact with peptide- and lipid-
laden MHC and CD1 molecules, respectively. 
The MHC is highly polymorphic, and distinct 
features within the peptide-binding groove 
enable the MHC to present a wide array of 
peptides to the T cells. Nevertheless, TCRs 
are highly specifi  c and genetically restricted 
to recognize MHC molecules of the individ-
ual from which they were derived (  1  ). In 
contrast, CD1 family members are mono-
morphic glycoproteins that are recognized 
by T cells from diff  erent individuals, and even 
across species in the case of CD1d. On the 
basis of their structural and functional fea-
tures, the CD1 family is predominantly di-
vided into group I CD1a, CD1b, and CD1c 
molecules, and the group II CD1d molecule, 
the latter of which is the only member of the 
family expressed in mice and rats. The Ag-
binding cleft of the CD1 family contains 
large hydrophobic pockets that are suited to 
bind lipid-based antigens. Recent structural 
studies have highlighted how diff  erent-sized 
cavities among the CD1 family enable it to 
bind defi  ned lipids (  2, 3, 4  ). For example, 
the CD1d family binds a restricted repertoire 
of glycolipids, which includes foreign glyco-
lipids such as the glycosphingolipid      -galac-
tosylceramide (     -GalCer) (  5  ), which is an 
archetypal CD1d ligand that binds well to both 
human (hCD1d) and mouse CD1d (mCD1d) 
molecules (  6, 7  ). 
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  Although it has been established how CD1 binds a variety of lipid antigens (Ag), data are 
only now emerging that show how          T cell receptors (TCRs) interact with CD1-Ag. Using 
the structure of the human semiinvariant NKT TCR  –  CD1d  –      -galactosylceramide (    -GalCer) 
complex as a guide, we undertook an alanine scanning mutagenesis approach to defi  ne the 
energetic basis of this interaction between the NKT TCR and CD1d. Moreover, we explored 
how analogues of     -GalCer affected this interaction. The data revealed that an identical 
energetic footprint underpinned the human and mouse NKT TCR  –  CD1d  –      -GalCer cross-
reactivity. Some, but not all, of the contact residues within the J    18-encoded invariant 
CDR3     loop and V    11-encoded CDR2     loop were critical for recognizing CD1d. The resi-
dues within the V    24-encoded CDR1     and CDR3     loops that contacted the glycolipid 
Ag played a smaller energetic role compared with the NKT TCR residues that contacted 
CD1d. Collectively, our data reveal that the region distant to the protruding Ag and 
directly above the F     pocket of CD1d was the principal factor in the interaction with the 
NKT TCR. Accordingly, although the structural footprint at the NKT TCR  –  CD1d  –      -GalCer 
is small, the energetic footprint is smaller still, and reveals the minimal requirements for 
CD1d restriction. 940 NKT T CELL RECEPTOR RECOGNITION | Wun et al.
  It is unclear, however, whether the principles underly-
ing            TCR  –  pMHC recognition will be applicable to 
that of            TCR  –  CD1 interactions, and this consideration 
has been hampered because of a lack of structural informa-
tion on            TCR  –  CD1  –  Ag complexes. Nevertheless, recent 
insight has been gained into lipid-mediated recognition, 
with the structure determination of the NKT TCR in the 
nonliganded state (  25, 26  ) and in complex with CD1d  –       -
GalCer (  27  ). Moreover, a recent study has highlighted the 
important mouse NKT TCR residues that are critical for 
mouse CD1d-Ag recognition, although the structure of 
the mouse NKT TCR  –  CD1d  –  Ag complex is unknown 
(  28  ). To establish the underlying energetic basis of this hu-
man NKT TCR  –  CD1d  –       -GalCer interaction, we under-
took an alanine scanning approach using surface plasmon 
resonance, which has revealed the minimal requirements 
to enable CD1d-Ag recognition. 
    RESULTS   
  Experimental rationale 
  To defi  ne the underlying energetic basis of the interaction 
between the NKT TCR and CD1d  –       -GalCer, we under-
took an alanine scanning approach on both the NKT TCR 
and CD1d binding partners. We analyzed the eff  ect of the 
mutations on the interaction using surface plasmon reso-
nance. Given that the structures of the NKT TCR and CD1d  –
       -GalCer are available in the nonliganded state and in 
complex with CD1d  –       -GalCer, we were able to rational-
ize the NKT TCR and CD1d residues selected for muta-
tional analysis. Solvent-exposed NKT TCR residues whose 
sidechains interacted with either CD1d and/or      -GalCer 
were selected for substitution to alanine (  Fig. 1 A  ).   CD1d 
residues selected for substitution were those that made 
contact with the NKT TCR, but were not involved in 
contacting      -GalCer, as mutation of these latter residues 
(Tyr73, Ser76, Phe77, Asp80, Phe84, Asp151, Trp153, 
and Thr154) were considered likely to impact on the pre-
sentation of the ligand. 
  NKT TCR substitutions 
  In brief, the NKT TCR  –  CD1d  –       -GalCer complex revealed 
that the CDR1      loop solely contacted the Ag, whereas 
the CDR3      loop contacted CD1d and the Ag, whereas con-
tributions from the V      chain predominantly arose via the 
CDR2      loop contacting CD1d (  Fig. 1 A  ). In the original 
study on the 3.2   Å   crystal structure of NKT TCR  –  CD1d  –       -
GalCer complex, there were two ternary complexes within 
the asymmetric unit. Subtle diff  erences in the NKT TCR-
CD1d contacts between these two ternary complexes were 
observed (  Table I  ), which could potentially help to further 
refi  ne the residues important in the interaction; alternatively, 
these diff  erences may either be a consequence of crystal-
packing eff  ects or be a function of refi  ning a ternary complex 
at 3.2   Å   resolution.   As such, we decided to mutate all NKT 
TCR residues implicated in the interaction with CD1d  –       -
GalCer and in total, 14 NKT TCR amino acid substitutions 
  Structural studies on TCR  –  peptide  –  MHC complexes 
have revealed markedly differing docking strategies in 
which TCRs can interact with peptide-MHC ligands 
(pMHC) (  8, 9  ). Nevertheless, a rough docking mode is 
preserved, in which the V      domain is positioned over 
the      2-helix and the N-terminal end of the peptide, 
while the V      domain is positioned over the      1-helix and 
C-terminal end of the peptide. These studies have been 
complemented by biophysical studies (e.g., surface plas-
mon resonance) of the TCR  –  pMHC interaction, which 
have demonstrated that the TCR  –  pMHC interaction 
is dominated by weak intermolecular interactions (low 
  micromolar range), with slow association rates and fast 
dissociation rates (  10, 11  ). Moreover, alanine-scanning 
mutagenesis has been important in understanding the en-
ergetic basis of the TCR  –  pMHC interaction, and to 
date, has been conducted in several TCR  –  pMHC sys-
tems (  12  –  15  ). These studies have revealed that the ener-
getic contributions of the CDR loops can vary quite 
considerably at the TCR  –  pMHC interface, as well as be-
tween different TCR  –  pMHC systems. For example, in 
the 2C TCR system, the CDR1 and CDR2 loops were 
shown to be critically important (  13  ), whereas in the 
LC13 TCR system, the CDR3 loops contributed mostly 
to the energetic landscape (  14  ). Moreover, studies on the 
I-E  k  -moth cytochrome   c   system has suggested a two-step 
mechanism for TCR recognition of the pMHC complex, 
whereby the CDR1 and CDR2 loops initially contact 
the MHC, followed by the CDR3 loops contacting the 
peptide (  15  ). 
  NKT cell activation is implicated in many aspects of 
immunity and can enhance the response to some bacterial, 
viral, and parasitic infections, and some types of cancer, 
yet can suppress autoimmune disease, allograft rejection, 
and graft-versus-host disease (  16  ). Type I NKT cells typi-
cally express a semiinvariant            TCR (NKT TCR) that 
comprises an invariant       chain, and a limited TCR      rep-
ertoire. The NKT TCR binds to CD1d, which can pres-
ent self- or foreign glycolipid to NKT cells. The human 
invariant NKT TCR      chain uses a V    24-J     18 (TRAV10-
TRAJ18) rearrangement that encodes a germline-encoded 
junctional sequence, preserving amino acid sequence iden-
tity among human NKT TCR       chains. Moreover, most 
type I human NKT cells express V     11 (TRBV25-1) (  17  ) 
rearranged to form variable D          J      combinations with 
N-region additions or deletions (  18  –  21  ). In addition, some 
CD1d-restricted, V     24-independent NKT TCRs have 
been described that nevertheless maintain J     18 and V     11 
usage (  18, 22  ), but these are less well studied. In addition 
to being highly selected, the human invariant NKT TCR 
(V     24-J     18; V     11) and the mouse NKT TCR homo-
logue (V     14-J     18; V     8.2) (  17  ) are cross-species reactive 
with mouse and human CD1d, respectively (  23, 24  ). Such 
evolutionary conserved recognition is contrary to the highly 
restricted syngeneic TCR recognition of MHC class I and 
II molecules. JEM VOL. 205, April 14, 2008 
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panel of conformation-sensitive mAbs reactive against re-
gions of the V     24 (A2G10) and V     11 (1A6 and A2G6) 
variable domains and the TCR constant domain (12H8). 
However, the Pro28     Ala mutant was the exception, as there 
was no reactivity with the V     24 (A2G10) mAb, but equal 
reactivity with mAbs toward the V     11 (1A6 and A2G6) and 
constant domain (12H8). Accordingly, the controls were 
consistent with the NKT TCR mutants; with the exception 
of Pro28     , they all retained their native conformation (un-
published data). 
  Varying concentrations of the NKT TCR were passed 
over a research-grade streptavidin sensor chip (GE Health-
care) coupled with biotinylated mouse or human CD1d loaded 
with      -GalCer and the corresponding unloaded equiva-
lents. The fi  nal response was determined by subtracting 
the unloaded CD1d response from the CD1d  –       -GalCer 
response and the equilibrium binding constant (  K    deq  ) was 
calculated (  Fig. 2, A  –  C  ).   The interaction of WT NKT 
TCR and human CD1d  –       -GalCer had a   K    deq   of     0.5   ±   
0.05   μ  M, whereas the   K    deq   for mouse CD1d  –       -GalCer 
was     0.9   ±   0.13   μ  M (  Table I  ) and were broadly consis-
tent with previous measurements (  25, 26  ). Although these 
WT   K    deq   measurements were reproducible on two sepa-
rate occasions and using two separate batches of WT NKT 
TCR, we nevertheless considered it important that all the 
mutant NKT TCR proteins were analyzed in the same 
experiment, in duplicate and relative to the same batch of 
WT NKT TCR. This was to ensure that all the   K    deq   val-
ues were comparable and relative to one another (  Table I  ). 
NKT TCR substitutions that caused less than a fourfold 
loss in the affi   nity of the interaction with CD1d  –       -GalCer 
compared with WT NKT TCR were considered to have 
no major eff  ect. NKT TCR substitutions that caused more 
than a 10-fold loss in binding affi   nity were considered cru-
cial to the energetics of the interaction. In each instance, 
the eff  ect of the NKT TCR substitution on the affi   nity of 
the interaction was essentially consistent between mouse 
and human CD1d  –       -GalCer. 
  The CDR1     loop 
  We mutated Pro28      and Ser30      within the CDR1      loop, 
both of which interact exclusively with the galactose moi-
ety of      -GalCer (  Fig. 1 B  ). The Ser30     Ala substitution did 
not alter the affi   nity of the interaction with hCD1d  –       -Gal-
Cer, even though it forms H-bonds and van der Waals (vdw) 
contacts with the 3     - and 4     - hydroxyls of the galactose 
moiety, respectively (  Fig. 1 B  ). This lack of eff  ect was sur-
prising, as the mouse NKT TCR can distinguish between 
     -GalCer analogues that possess minor structural modifi  ca-
tions on the saccharide, such as the positioning of the 2      and 
4      hydroxyls in      -ManCer (  29  ). Although the Ser at position 
30 is not conserved in the mouse NKT TCR homologue, the 
equivalent substitution in the mouse system (Asn30       →  Ala) 
resulted in a greater than twofold loss of binding of mCD1d 
tetramers loaded with      -GalCer and the      -GalCer ana-
logues PBS57 and OCH9 (  28  ). 
were made and included CDR1      (Pro28      and Ser30     ); 
CDR3      (Asp94     , Arg95     , Gly96     , Ser97     , Thr98     , 
Leu99     , and Arg103     ); CDR2      framework (Tyr48      and 
Glu56     ); CDR2      (Tyr50      and Asn53     ); and CDR3      
(Tyr103     ). All of the mutant NKT TCR proteins expressed 
and refolded with similar yield to WT NKT TCR, except 
for Asp94     , which produced half the amount of protein dur-
ing expression but has the same refold effi   ciency as the WT. 
These mutant NKT TCR proteins behaved similarly to the 
WT NKT TCR in gel fi  ltration and analysis under reducing 
and nonreducing SDS-PAGE. Furthermore, the NKT TCR 
mutant proteins were as reactive as the WT NKT TCR to a 
    Figure 1.         A NKT TCR CDR3     and CDR2     loop contacts dominate 
CD1d-mediated interactions  . (A) Residues on the NKT TCR important 
for recognizing CD1d  –       -GalCer. (B) CDR1      loop interacts solely with 
     -GalCer galactose head group. (C) CDR3      loop mediates multiple contacts 
between CD1d      -helices and      -GalCer. (D) CDR3      loop contacts with the 
CD1d      2-helix. (E) Residues within and next to the CDR2      loop  make 
polar interactions with the CD1d      1-helix. Pink,      -GalCer; yellow, CDR1     
loop; cyan, CDR3     ; orange; CDR2      loop; blue, CDR3      loop; grey, CD1d 
     -helices. H-bond or salt-bridge interactions, dotted lines. In   Fig. 1 (B  –  E)  , 
substituted residues with a   >  10-fold reduction in affi  nity are shown in 
red; with a 4  –  6-fold reduction in affi  nity are shown in green; and with a 
  <  4-fold reduction in affi  nity are shown in blue.     942 NKT T CELL RECEPTOR RECOGNITION | Wun et al.
Gly96     Ala substitution was surprising, however, as the 
main chain of Gly96      H-bonded to the 2     -OH of      -Gal-
Cer and also interacted with the 3     -OH of      -GalCer and 
residues within the      2-helix of CD1d. Nevertheless, four 
(Asp94     , Arg95     , Ser97     , and Leu99     ) of the seven resi-
dues substituted within the CDR3      loop of the NKT TCR 
had a marked eff  ect on the affi   nity of the interaction with 
hCD1d  –       -GalCer (  Table I   and   Fig. 1 C  ). The substitutions 
at these critical positions would result in the loss of salt-
bridging interactions with Arg79 and Asp80, and vdw inter-
actions with Ser76 from the      1-helix of CD1d, as well as 
vdw interactions with residues from the      1- and      2-helices 
of CD1d. Accordingly, some, but not all of the residues in 
the strictly conserved J     18 gene are critically important in 
the recognition of CD1d. 
  The CDR3     loop 
  Tyr103     , which is located on the J      gene segment of the 
CDR3      loop of the NKT TCR, is the sole CDR3      res-
idue that contacts CD1d. The Tyr103     Ala substitution 
resulted in the loss of a vdw contact with the      2-helix of 
  Pro28      contacts the 6     -OH and 5     -O of the galactose 
moiety of      -GalCer. Although the Pro28     Ala substitu-
tion had a marked eff  ect on the affi   nity of the interaction 
with hCD1d  –       -GalCer, our mAb reactivity data suggests 
the Pro28     Ala substitution had an overall eff  ect on the 
conformational integrity of the V     24 domain of the NKT 
TCR, making it diffi   cult to determine whether this substi-
tution was important in the interaction. 
  The CDR3     loop 
  Seven mutations were made in this loop (  Table I   and   Fig. 1, 
A and C  ), three of which (Gly96     , Thr98     , and Arg103     ) 
had a negligible eff  ect on the affi   nity of the interaction. The 
lack of an eff  ect with the Thr98     Ala substitution was not 
surprising, as the cross-reactive mouse NKT TCR possesses 
an Ala at that position (  Fig. 3 A  ).   Even though Arg103      is 
conserved in the mouse NKT TCR homologue, its substi-
tution to Ala had no eff  ect on the recognition of hCD1d  –
       -GalCer. This residue forms an H-bond with the Arg79 
on the      1-helix of CD1d in one ternary complex within 
the asymmetric unit (  Table I  ). The lack of eff  ect of the 
    Table I.        The effect of NKT TCR alanine substitutions on CD1d  –      -GalCer  binding 
Residue mouse CD1d   K    deq  human CD1d   K    deq  human CD1d  –      -GalCer contact Effect on 
  affi  nity
   μ M      μ M 
NKT WT 0.94   ±   0.13 0.46   ±   0.05   –   – 
CDR1    
     Pro28     4.75   ±   0.13 5.44   ±   0.23      -GalCer Galactose; 6     -OH, 5     -O ***
     Ser30       1.16   ±   0.05 0.70   ±   0.07      -GalCer Galactose; 3     -OH, 4     -OH *
CDR3    
     Asp94       a    >  58   >  58      1-helix; Arg79 ***
     Arg95         a      >  58   >  58      1-helix; Ser76, Arg79, Asp80 
       -GalCer Galactose; 2     -OH, C-2 
  Sphingosine; 3     -OH, 4     -OH, C-3, C-4
***
     Gly96       a
  1.19   ±   0.12 1.07   ±   0.13      2-helix; Gln150, Asp151 
       -GalCer Galactose; 2     -OH, 3     -OH, C-2
*
     Ser97         a      >  58   >  58      2-helix; Val147, Gln150 ***
     Thr98     0.90   ±   0.05 0.81   ±   0.07      2-helix; Gln150 *
     Leu99   a
    >  58   >  58      1-helix; Asp80, Phe84; 
       2-helix; Val147
***
     Arg103       a
  2.56   ±   0.24 0.39   ±   0.06      1-helix; Arg79      c     *
CDR2    
     Tyr48   b
    >  30   >  30      1-helix; Glu83, Lys86 ***
     Tyr50       >  25   >  25      1-helix; Glu83, Met87 ***
     Asn53     1.19   ±   0.12 0.73   ±   0.09      1-helix; Arg89      c     *
     Glu56       b
  0.72   ±   0.11 0.40   ±   0.03      1-helix; Lys86 *
CDR3    
     Tyr103     0.82   ±   0.06 0.71   ±   0.13      2-helix; Gln150 *
* represents an effect in which NKT TCR alanine substitution results in a   <  4-fold reduction in binding to CD1d  –       -GalCer compared to the WT value. *** represents an effect in 
which NKT TCR alanine substitution with a   >  10-fold reduction in binding to CD1d  –       -GalCer when compared to the WT value.
  a  Conserved between the human J     18 gene segment and the mouse J     18 gene segment homologue.
  b CDR2     framework residues.
  c  Denotes contacts that are not maintained in the second NKT TCR  –  CD1d  –       -GalCer complex within the asymmetric unit.JEM VOL. 205, April 14, 2008 
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  The CDR2     loop 
  The CDR2      loop dominated contacts from the V     11 chain 
of the NKT TCR. Four residues within or surrounding 
this loop were mutated, but only two of these residues, 
Tyr48      and Tyr50     , were critical to the energetics of the 
interaction. These residues are conserved within the mouse 
NKT TCR homologue and H-bonded to Glu83 and 
Lys86, as well as forming vdw interactions with residues 
from the      1-helix (  Fig. 1 E  ). Asn53      and Glu56      were 
shown to be nonessential residues in the interaction. Ac-
cordingly, only two aromatic residues within and next to 
the CDR2      loop are critical for the interaction with 
CD1d  –       -GalCer. 
  CD1d substitutions 
  Based on the crystal structure of the NKT TCR  –  CD1d  –
       -GalCer complex, six   “  alanine-scanning  ”   CD1d mutants 
were produced, including Arg79, Glu83, Lys86, and Met87 
on the CD1d      1-helix and Val147 and Gln150 on the      2-
helix. The CD1d mutant proteins were expressed at simi-
lar levels to WT CD1d, behaved similarly under reducing 
and nonreducing SDS-PAGE, and were as reactive in an 
ELISA probed with anti  –  human CD1d mAb 51.1 (unpub-
lished data) (  30  ). CD1d proteins were biotinylated, loaded, 
and coupled to a research-grade streptavidin sensor chip 
and analyzed for their reactivity against varying concentra-
tions of the WT NKT TCR after the subtraction of the 
unloaded CD1d response (  Fig. 2 D  ). 
  The eff  ect of the CD1d substitutions can be grouped 
into the following three categories: no eff  ect, a moderate 
eff  ect of 4  –  6-fold loss of affi   nity, and a drastic eff  ect of   >  10-
fold loss of affi   nity (  Table II  ).   Arg79, which contacts three 
residues within the J     18 region, was the only CD1d resi-
due whose substitution had no eff  ect on the interaction 
with the NKT TCR (  Table II  ). Two of the substitutions 
that had the greatest impact on affi   nity included Glu83 and 
Met87, which are both located on the      1-helix of CD1d. 
These substitutions would result in a loss of contacts with 
Tyr48      and Tyr50      on the CDR2      loop, thereby corre-
lating with the CDR2      mutagenesis (  Table I  ). Consistent 
with our observation, a mouse CD1d transfectant bearing 
an Ala substitution at position 83 showed impaired stimu-
lation of semiinvariant mouse NKT cells (  31, 32  ). In addi-
tion, Lys86 contacts Tyr48      from the CDR2      loop and 
also salt bridges to Glu56     , and the Lys86 to Ala substitu-
tion had a moderate eff  ect on the interaction with the 
NKT TCR. 
  Two CD1d residues located on the      2-helix (Val147 and 
Gln150) were substituted, and each had a moderate eff  ect on 
the affi   nity of the interaction with the NKT TCR (  Table II  ). 
Both contacted residues within the highly selected J     18 seg-
ment of the NKT TCR, with the former making vdw con-
tacts with Ser97      and Leu99     , and the latter with Gly96     , 
Ser97     , Thr98     , and Tyr103     . The eff  ect of the Val147 to 
Ala mutant concurs with the NKT TCR mutagenesis data, 
whereby the reciprocal substitutions of both Ser97      and 
hCD1d, but this loss was inconsequential to the affi   nity of 
the interaction with hCD1d  –       -GalCer, further highlight-
ing the lack of a role of the CDR3      loop of this NKT 
TCR in the interaction with CD1d  –       -GalCer (  Fig. 1 D  ). 
    Figure 2.         Binding analysis of NKT TCR to human and mouse 
CD1d  –      -GalCer using surface plasmon resonance  . A concentration 
series of the WT NKT TCR was passed over human CD1d  –       -GalCer (A) and 
mouse CD1d  –       -GalCer (B). (insets) The equilibrium response versus con-
centration.     (C) Comparison of the relative response of 10   μ  M of the WT 
NKT TCR and the Asn53      and  Arg95     mutant NKT TCRs to human CD1d  –
     -GalCer. (D) Comparison of the relative response of 6.25   μ  M WT NKT TCR 
to WT human CD1d  –       -GalCer and the CD1d mutant proteins carrying 
Arg79 and Glu83 substitutions. 944 NKT T CELL RECEPTOR RECOGNITION | Wun et al.
(  Fig. 4 A  ).   The substitutions that had a marked eff  ect on the 
affi   nity of the interaction formed a central hotspot over the 
surface of the antigen-binding domain, whereas noncritical 
residues were located peripheral to the hotspot (  Fig. 4 A  ). The 
hotspot included some of the residues from the CDR3      loop 
(Asp94     , Arg95     , Ser97     , and Leu99     ), residues from within 
or surrounding the CDR2      loop (Tyr48      and Tyr50     ). 
  Similarly, to defi  ne CD1d residues that were critical to 
the NKT TCR interaction, we mapped the residues that 
were substituted in this study, highlighting residues that formed 
crucial contacts with the NKT TCR (  Fig. 4 B  ). The CD1d 
Leu99      resulted in a marked loss of recognition of CD1d  –       -
GalCer. On the other hand, not all of the NKT TCR contacts 
of CD1d residue Gln150 were detrimental to the recognition 
event when they themselves were substituted. Indeed, only 
the Ser97      substitution caused a loss, again highlighting the 
important role of this CDR3      residue. 
  The energetic hotspots 
  Next, we mapped the location of NKT TCR residues that 
were substituted in this study onto the structure of the NKT 
TCR to ascertain the location and size of the energetic hotspot 
    Figure 3.         Sequence alignment of CD1d and the NKT TCR from both human and mouse  . Sequence comparison of the CDR1    ,  CDR3   ,  and  CDR2    
loops of the mouse and human NKT TCR homologues (A) and the CD1d      1- and      2-helices (B). Substituted residues that have a   >  10-fold reduction in 
affi  nity are shown in red; a 4  –  6-fold reduction in affi  nity are shown in green; and a   <  4-fold reduction in affi  nity are shown in blue; residues that contact 
either  CD1d –     -GalCer or the NKT TCR that were not substituted, purple.     
    Table II.        The effect of CD1d alanine substitutions on NKT TCR binding 
NKT15   K    deq  NKT15 contact Effect on affi  nity
     μ M 
WT human CD1d 0.58   ±   0.13   - -
Arg79A      a    0.35    ±   0.02 Asp94     , Arg95     , Arg103           b    J     *
Glu83A      a      >  25 Tyr48     , Tyr50    2     ***
Lys86A      a    2.83    ±   0.13 Tyr48    2     **
Met87A      a    7.9    ±   0.32 Tyr50    2     ***
Val147A      a      3.6   ±   0.17 Ser97     , Leu99    J     **
Gln150A 2.5   ±   0.19 Gly96     , Ser97     , Thr98     , Tyr103    J     **
* represents CD1d alanine substitution with   <  4-fold reduction in binding to NKT TCR compared to the WT value; ** represents CD1d alanine substitution resulting in a 4  –  6-
fold reduction in binding to NKT TCR compared to the WT value; and *** represents CD1d alanine substitution resulting in a   >  10-fold reduction in binding to NKT TCR 
compared to the WT value.
  a  Conserved between human and mouse CD1d.
  b  Denotes contacts that are not maintained in the second NKT TCR  –  CD1d  –       -GalCer complex within the asymmetric unit.JEM VOL. 205, April 14, 2008 
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CD1d      1- and      2-helix, including Lys86, Val147, and 
Gln150, also caused a moderate loss in the affi   nity of the 
interaction. Collectively, these and previous mutagenesis 
results indicate that the CD1d energetic footprint is local-
ized and centrally located above the F      pocket of CD1d 
(  Fig. 4, B and C  ). 
  Cross-species reactivity 
  In addition to examining the eff  ect of the 14 NKT TCR 
mutations on the interaction with hCD1d, we also ex-
amined the eff  ect of these mutations on the interaction 
with mCD1d  –       -GalCer (  Table I  ). Although the interac-
tion with mCD1d was consistently approximately twofold 
weaker when compared with hCD1d, the eff  ect of the 
NKT TCR mutations on the mCD1d interaction essen-
tially parallelled that observed in our hCD1d  –       -GalCer 
study (  Table I  ). Moreover, of the six residues that were 
important in the NKT TCR, Asp94     , Arg95     , Ser97     , 
Leu99     , Tyr48     , and Tyr50      are all conserved in the 
mouse V     14J     18-V     8.2 NKT TCR (  Table I   and   Fig. 3 A  ). 
Consistently, mouse NKT cells expressing TCRs with 
these identical individual substitutions (with the exception 
of Tyr48     , which was not tested) had a marked reduction 
in mCD1d  –       -GalCer tetramer binding (  28  ). Furthermore, 
of the fi  ve CD1d residues that had a moderate-to-marked 
eff  ect on the binding of the NKT TCR (Glu83, Lys86, 
Me87, Val147, and Gln150), all but one are conserved in 
the mouse CD1d homologue (Gln150 to Ala 152;   Table II   
and   Fig. 3 B  ). Collectively, these results indicate that a 
similar footprint underpins the human  –  mouse cross-spe-
cies reactivity, which is reinforced by sequence and struc-
tural analyses. 
      -GalCer analogues 
  Having shown which NKT TCR residues are required to 
interact with hCD1d, and that a common structural foot-
print underpins the reciprocal cross-species reactivity, we 
then probed the role of the CDR1      loop in interacting 
with the      -GalCer. Given that the majority of the CDR1     -
mediated interactions are with the 3     - and 4     -hydroxyl 
groups of      -GalCer, we used      -GalCer analogues defi  -
cient in either one of these groups. First, we used mouse 
CD1d tetramers loaded with the      -GalCer analogues and 
assessed the role these modifi  cations had on the staining of 
cells expressing the WT mNKT TCR and CDR1      mu-
tants thereof (  Fig. 5  ).   The data indicated that WT mNKT 
TCR could interact with all three analogues of      -GalCer 
in the following order:      -GalCer  >  4     -deoxy  ≈  3     -deoxy. Of 
the alanine-scanning mutations, positions 26 and 28 are 
likely to aff  ect the conformation and/or mobility of the 
CDR1      loop, thereby highlighting the overall impor-
tance of the conformation of this loop in recognition of 
     -GalCer. Positions 29, 32, and 33 are, by analogy to the 
human NKT TCR  –  CD1d complex, unlikely to participate 
in contacting      -GalCer, and this was evident from the 
mutagenesis data. However, the substitutions at positions 
substitutions that caused the greatest loss of NKT TCR 
recognition included Glu83 and Met87, indicating the 
disruption of contacts with the      1-helix were the most 
critical. However, the substitution of other residues on the 
    Figure 4.         Energetic hotspots.   (A) The NKT TCR hotspot. Surface repre-
sentation of the NKT TCR molecule. Yellow, V     ; pale blue, V     . The NKT TCR 
CDR1    ,  3   ,  2    , and 3      loops and the CD1d      1- and     2-helices  are 
shown as a cartoon representation. (B) The human CD1d hotspot. Surface 
representation of the human CD1d molecule presenting     -GalCer  (pink 
ball and stick). A cartoon representation of the CD1d      -helices and se-
lected CDR loops are also displayed (C) Critical residues for NKT TCR  –
 CD1d –     -GalCer recognition are biased toward the F      pocket  region. 
Substituted residues that have   >  10-fold reduction in affi  nity are shown in 
red; 4  –  6-fold reduction in affi  nity are shown in green;   <  4-fold reduction 
in affi  nity are shown in blue; residues that were not substituted are 
shown in purple;      -GalCer is shown in pink; CDR1      loop is shown in 
yellow; CDR3      is shown in cyan; CDR2      loop is shown in orange; CDR3     
loop is shown in blue; and CD1d      -helices are shown in grey.     946 NKT T CELL RECEPTOR RECOGNITION | Wun et al.
30 and 31 of the mNKT TCR are likely to be more spe-
cifi  c in the disruption of contacts with CD1d  –       -GalCer. 
Overall, the mutations indicate that substitutions at the 
3     -OH are less well tolerated than substitutions at the 4     -OH 
for      -GalCer. 
  Furthermore, to account for the sequence variation be-
tween the mouse and human CDR1      loops, we reverted 
single substitutions within the mouse NKT TCR CDR1      
loop back to their human counterpart, i.e., Asn30     Ser and 
His31     Asn and also the double Ser-Asn mutant at posi-
tions 30 and 31. In comparison to the alanine-scanning 
mutants, the binding affi     nity of these mutants was more 
  comparable to the WT mNKT TCR, indicating that the 
sidechains at positions 30 and 31 contribute some energy, 
albeit modest, to the interaction (  Fig. 5  ). For example, the 
hNKT TCR  –  CD1d  –       -GalCer structure reveals that Ser30      
H-bonded to the 3     -OH of      -GalCer. This is consistent 
with the Asn30Ser mutant not being able to rescue binding 
to the 3     -deoxy derivative of      -GalCer, yet can partially 
improve the binding affi   nity of the 4     -deoxy derivative. 
Interestingly, the Asn30Ala mutant appeared to aff  ect 
the binding to the 3     - and 4     -deoxy derivatives of      -
GalCer (  Fig. 5  ), which, unlike Ser30      of hNKT TCR, 
suggests that Asn30 of mNKT TCR forms H-bonds to 
both these moieties, which would be consistent with its 
longer sidechain. 
    DISCUSSION   
  At a structural level, the vast T cell repertoire is manifested 
in the various ways in which a TCR can interact with the 
polymorphic pMHC. Despite the repertoire diversity, ex-
amples of TCR bias have emerged in antiviral immunity, 
and such biased TCR usage has been correlated with the 
recognition of atypical pMHC landscapes (  33  ). The hu-
man semiinvariant NKT TCR is an example of biased 
TCR usage directed against a monomorphic CD1d mole-
cule, in which the NKT TCR       chain is invariant and 
the       chain is restricted to V     11 usage, albeit with variable 
CDR3      usage. In comparison to the previously determined 
TCR  –  pMHC complexes, the NKT TCR adopted an unusual 
docking strategy to interact with the featureless CD1d  –       -
GalCer complex (  27  ). We therefore sought to determine 
the energetic landscape of the NKT TCR  –  CD1d  –       -Gal-
Cer interaction. 
  Our observations demonstrate that although the NKT 
TCR structural footprint is small, the energetic footprint 
is smaller still, as not all of the residues of the NKT TCR 
that mediated contacts with CD1d  –       -GalCer contributed 
to the energetic landscape of the interaction. Namely, we 
substituted 14 residues of the NKT TCR that contact CD1d  –
       -GalCer and of these, only 6 contributed to the energetic 
    Figure 5.             -GalCer analogues.   (A) Hybridomas expressing wild-type 
mouse V    14i  TCR     chain were subjected to staining with the indicated 
dilutions of mouse CD1d tetramers left unloaded or loaded with     -GalCer, 
3    deoxy-   -GalCer,  or  4 ’ deoxy-    -GalCer, and mean fl  uorescence intensity 
(MFI) of tetramer staining was determined from a thin TCR gate. MFI of 
background staining with unloaded tetramer was determined for each 
concentration and subtracted from the MFI of loaded tetramer. Data 
points represent the mean of MFI   ±   the range from two independent 
experiments. (B) Hybridomas expressing WT or indicated mutations of 
mouse V    14i  TCR     chain were subjected to staining with mouse CD1d 
tetramers loaded with      -GalCer (top), 3    deoxy-    -GalCer (middle), or 
4 ’ deoxy-    -GalCer (bottom). Nonmutated V    14-J   18  TCR     chain  served 
as the WT control. The negative control was a V    14-J    18 construct in 
which the V     14 CDR1 region was swapped for the V    3.2  CDR1     region 
(V     3.2). MFI of tetramer staining for all mutants was determined from a 
thin TCR gate. Error bars represent the mean of MFI   ±   the range for two 
independent  experiments.   
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a greater infl  uence on the recognition of other ligands bound 
to CD1d, and this was analyzed using analogues of      -Gal-
Cer. It was clear that the mNKT TCR could interact with 
the 3     - and 4     -deoxy-galactosyl ceramides, which is con-
sistent with the hNKT TCR CDR1      mutagenesis (  Table I  ). 
Nevertheless, the alanine-scanning and   “  humanized  ”   mu-
tagenesis on the CDR1      loop indicated that removal of 
the 4     -OH moiety was more tolerated than the 3     -OH 
substitution. The apparent adaptability of the CDR1       –       -Gal-
Cer interactions is consistent not only with the relatively 
low sequence conservation in the CDR1      loop between the 
mouse and human NKT TCRs (  17  ), but also the presence 
of some CD1d-restricted,      -GalCer  –  reactive, V     24-neg-
ative NKT TCRs that diff  er in the sequence of the CDR1      
loop (  22, 26  ). 
  In contrast to TCR  –  pMHC interactions, the NKT TCR 
exhibits reciprocal cross-species reactivity, and the eff  ects 
of the NKT TCR mutations display an identical pattern 
when interacting with human CD1d or mouse CD1d, 
suggesting that the human NKT TCR will dock in a very 
similar manner on mouse CD1d compared with human 
CD1d. The similarity of the human NKT TCR footprint 
on both mouse and human CD1d molecules appears to 
engender reciprocal cross-reactivity. In summary, the mark-
edly diff   erent docking strategies between TCR  –  pMHC 
and TCR  –  CD1d complexes are also mirrored by diff  erences 
in the energetic footprints between peptide and glycolipid-
restricted TCRs. 
    MATERIALS AND METHODS   
  Protein expression, refolding, and purifi  cation.     The cloning, ex-
pression, and purifi  cation of the human NKT TCR used in this study 
(      chain: TRAV10-TRAJ18;       chain TRBV25-1, TRBD1 and TRBJ2-7, 
with CDR3      sequence   92  CASS  95     96  GLRDRGL  102     103  Y  105  EQYFG-
PGTRLTVT  117  ; and NKT15) has been previously described (  25  ). However, 
the NKT TCR proteins were further purifi  ed using hydrophobic interaction 
chromatography and a Phenyl HP HiTrap column (GE Healthcare). The 
NKT TCR was eluted with 20 mM Hepes, pH 7.4, and 0.8 M ammonium 
sulfate, concentrated, and buff  er-exchanged into 10 mM Hepes, pH 7.4, 150 
mM NaCl using a 30K Amicon Ultra-4 concentrator (Millipore). The clon-
ing, expression, purifi  cation, biotinylation, and loading of human CD1d 
have been previously described (  25  ). Purifi  ed, biotinylated mouse CD1d was 
supplied by D. Pellicci (University of Melbourne, Parkville, Victoria, Aus-
tralia) and was generated using a construct originally provided by M. Kro-
nenberg (University of Melbourne). 
  NKT TCR mutants.     The WT human NKT TCR      - or       chain DNA was 
used as the template to generate the NKT TCR mutants using site-directed 
mutagenesis (QuikChange; Stratagene). A total of 14 mutant NKT TCR mu-
tant proteins were made, each coding for a single amino acid substitution to 
Ala, and each was expressed and purifi  ed as per the WT human NKT TCR. 
  CD1d mutants.     WT CD1d DNA coding for a free C-terminal Cys was 
used to generate six CD1d mutants using site-directed mutagenesis. The 
CD1d mutant proteins each contained a single alanine substitution and 
were expressed in the baculovirus expression system. The mutant pro-
teins were purifi  ed, biotinylated, and loaded as per WT CD1d, and then 
coupled to a SA sensor chip for surface plasmon resonance analysis with 
WT NKT TCR. Anti-NKT TCR mAbs were provided by N. Crowe, 
K. Kyparissoudis, and D. Pellicci (University of Melbourne). 
footprint, with the CDR3      and CDR2      loops of the 
NKT TCR appearing to be the principal driving force of 
the interaction. The requirement of the CDR3      loop in 
the energetics of the interaction argues against the two-
step model in TCR-CD1d recognition. The NKT TCR 
and CD1d substitution results reveal that although only a 
few contacts are mediated via the V      domain, Tyr48     , 
Tyr50     , and the corresponding binding partners on CD1d 
are absolutely critical to the interaction. These two V      
residues have been identifi  ed as   “  recognition codons  ”   in 
class II  –  restricted mouse TCRs using the human V     11 
chain homologue V     8.2. The recognition codons are im-
plicated in restricting and defi  ning the binding orientation 
of the TCR onto the MHC by penetrating between resi-
dues on the MHC helices (  34  ). The general use of Tyr48      
and Tyr50      highlights a potential evolutionary role of the 
NKT TCR CDR2      loop for CD1d binding and the use 
of recognition codons for MHC-like molecules, although 
it should be noted that the   “  interaction codon  ”   sites in 
MHC and CD1d do not reside within structurally equiva-
lent regions (  35  ). 
  Although some residues from within the CDR3      loop 
were also deemed critical for the interaction with CD1d, 
Arg95      was the only energetically important residue that 
interacts with the Ag. Accordingly, NKT TCR residues 
interacting with the CD1d seemingly had a greater eff  ect 
on the energetics of the interaction than those directly con-
tacting the glycolipid ligand, at least in the case of      -GalCer. 
However, this fi  nding is anomalous given that      -GalCer is 
a requirement for the staining of NKT cells by CD1d          -
GalCer tetramers and for NKT cell activation. This sug-
gests that the      -GalCer ligand may play a less direct role 
in the NKT TCR interaction and a more prominent role 
in infl   uencing the conformation of residues on CD1d, 
which in turn may infl  uence NKT TCR recognition. In-
deed, a comparison of liganded versus unliganded CD1d  –
       -GalCer (  36  ) shows that four CD1d residues change 
conformation upon ligation, and all are located on a small 
stretch of the      1-helix just above the F      pocket. Further-
more, our CD1d substitution analysis revealed two resi-
dues that had a drastic eff  ect on the interaction with the 
NKT TCR (Glu83 and Met87) and both are located on 
the      1-helix above the F      pocket. Consistent with this 
notion, the conformation of CD1d has been proposed to 
modulate the affi   nity of the mouse NKT TCR to two lig-
ands (OCH9 and      -GalCer) that diff  er only in the length 
of the predominantly buried sphingosine chain (  37  ). 
  The apparent lesser contribution of the CDR1      loop 
was surprising, as this loop solely contacted the      -GalCer, 
and the loss of binding caused by the Pro28      Ala substitu-
tion may be attributable to local changes in the conformation 
of the loop. However, we cannot exclude the possibility 
that redundancy exists in the interactions between residues 
containing      -GalCer that would not have been detected 
in our single amino acid mutagenesis studies. It also re-
mains possible that substitutions within this loop may have 948 NKT T CELL RECEPTOR RECOGNITION | Wun et al.
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  ELISA.     The conformational integrity of the CD1d and NKT TCR pro-
teins was determined using an ELISA and relevant conformation-specifi  c 
mAbs. The integrity of the CD1d proteins was determined using an anti  –
  human CD1d mAb 51.1 (  30  ), whereas the conformation of the NKT 
TCR proteins was determined using a panel of mAbs including a V     24-
reactive mAb (A2G10), two V     11-reactive mAbs (A2G6; 1A6), and a 
pan-soluble            TCR-reactive mAb (12H8). ELISA plates were coated 
with the CD1d or NKT TCR proteins at 5 or 10   μ  g/ml, respectively, 
and tested against serial dilutions of the relevant mAbs. The ELISA was 
then probed with HRP anti  –  mouse IgG, followed by OPD substrate, 
and the ELISA plate read at 492 nm. WT CD1d and NKT TCR proteins 
were used as positive controls, whereas a recombinant V     24         V     11         
TCR, together with its cognate peptide-MHC ligand, was included as a 
negative control. All experiments were performed at least in duplicate. 
  Surface plasmon resonance measurements and analysis.     Equilibrium 
affi   nity measurements of the NKT TCR  –  CD1d  –       -GalCer interaction were 
determined by surface plasmon resonance and have been previously de-
scribed (  25  ). For the NKT TCR mutant analysis,     3,000 RU of biotinyl-
ated WT human and mouse CD1d were coupled to a SA sensor chip (GE 
Healthcare) and analyzed against twofold serial dilutions of the WT and mu-
tant NKT TCR. For the CD1d mutant analysis,     3,000 RU of human mu-
tant or WT CD1d protein was coupled to a SA sensor chip and analyzed 
against the WT NKT TCR. For both experiments, the analyte was passed 
over the sensor chip at 5   μ  l/min for 80 s at 25  °  C, and the fi  nal response was 
subtracted from that of unloaded CD1d. 
  Staining of hybridomas expressing mouse V    14i TCRs.     Hybridomas 
expressing WT or mutant mouse V     14i TCR chains were generated by ret-
roviral transduction of a hybridoma expressing only the DO-11.10 V     8.2 
TCR      chain, as previously described (  28  ). For staining with mouse CD1d 
tetramers, unloaded, biotinylated recombinant CD1d protein was provided 
by the National Institutes of Health core facility. For multimerization, mo-
nomeric biotinylated recombinant CD1d was incubated overnight with      -
GalCer, C3     -deoxy-     -GalCer, or C4     deoxy-     -GalCer in PBS and 0.05% 
Tween 20, followed by addition of streptavidin (SA)-PE. TCR-expressing 
hybridomas were costained at room temperature for 60 min with indicated 
tetramer plus anti-TCR      (H57-597; eBioscience) and data were acquired 
on a FACSCalibur or FACScan fl  ow cytometer (BD Biosciences). Data fi  les 
were analyzed using FlowJo software (Tree Star, Inc.) and mean fl  uorescence 
intensity was compared for all samples on a narrow TCR gate, as previously 
described (  28  ). 
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